161 related articles for article (PubMed ID: 23941968)
1. Budd-Chiari syndrome in very young adult patients with polycythemia vera: report of case series with good outcome with direct thrombin inhibitor treatment.
Goldstein G; Maor J; Kleinbaum Y; Palumbo M; Sidi Y; Salomon O
Blood Coagul Fibrinolysis; 2013 Dec; 24(8):848-53. PubMed ID: 23941968
[TBL] [Abstract][Full Text] [Related]
2. Budd-Chiari syndrome as the first manifestation of polycythemia vera in young women with inherited thrombophilic state: an aggressive form of myeloproliferative disorder requiring multidisciplinary management.
Breccia M; Morano SG; D'Andrea M; Russo E; D'Elia GM; Alimena G
Eur J Haematol; 2005 Nov; 75(5):396-400. PubMed ID: 16191089
[TBL] [Abstract][Full Text] [Related]
3. Familial polycythemia vera with Budd-Chiari syndrome in childhood.
Cario H; Pahl HL; Schwarz K; Galm C; Hoffmann M; Burdelski M; Kohne E; Debatin KM
Br J Haematol; 2003 Oct; 123(2):346-52. PubMed ID: 14531919
[TBL] [Abstract][Full Text] [Related]
4. Budd-Chiari syndrome in a young female with factor V Leiden mutation: successful treatment with lepirudin, a direct thrombin inhibitor.
Salmela B; Nordin A; Vuoristo M; Mäkisalo H; Numminen K; Lassila R
Thromb Res; 2008; 121(6):769-72. PubMed ID: 17928037
[No Abstract] [Full Text] [Related]
5. Ruxolitinib treatment in an infant with JAK2+ polycythaemia vera-associated Budd-Chiari syndrome.
Coskun ME; Height S; Dhawan A; Hadzic N
BMJ Case Rep; 2017 Jul; 2017():. PubMed ID: 28710306
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum erythropoietin levels in patients with Budd-Chiari syndrome secondary to polycythemia vera: clinical implications for the role of JAK2 mutation analysis.
Thurmes PJ; Steensma DP
Eur J Haematol; 2006 Jul; 77(1):57-60. PubMed ID: 16827884
[TBL] [Abstract][Full Text] [Related]
7. [Budd-Chiari syndrome and Vaquez disease: apropos of a case. Results of medical and surgical treatment of Budd-Chiari syndrome].
Szappanyos-Vuaridel D; Rudolf H; Wichser J; Loizeau E
Schweiz Med Wochenschr; 1986 Nov; 116(47):1648-51. PubMed ID: 3541173
[TBL] [Abstract][Full Text] [Related]
8. JAK2V617F mutation in a 9-year-old girl with polycythemia vera and Budd-Chiari syndrome: a case report.
Benedik-Dolničar M; Homan M; Brecelj J
J Pediatr Hematol Oncol; 2012 Apr; 34(3):243-4. PubMed ID: 21552144
[No Abstract] [Full Text] [Related]
9. Case 15-2006: the Budd-Chiari syndrome and V617F mutation in JAK2.
Spivak JL; Moliterno AR; Silver RT
N Engl J Med; 2006 Aug; 355(7):737; author reply 738. PubMed ID: 16914715
[No Abstract] [Full Text] [Related]
10. Hypereosinophilia, JAK2V617F, and Budd-Chiari syndrome: who is responsible for what?
Mishchenko E; Tadmor T; Schiff E; Attias D; Polliack A
Am J Hematol; 2011 Feb; 86(2):223-4. PubMed ID: 21264914
[TBL] [Abstract][Full Text] [Related]
11. Direct intrahepatic portocaval shunt for treatment of portal thrombosis and Budd-Chiari syndrome.
Pedersen MR; Molloy P; Wood D; Seetharam A
Ann Hepatol; 2016; 15(1):127-30. PubMed ID: 26626649
[TBL] [Abstract][Full Text] [Related]
12. Uncontrolled thrombocytosis in polycythemia vera is a risk for thrombosis, regardless of JAK2(V617F) mutational status.
Ohyashiki K; Akahane D; Gotoh A; Ito Y; Tauchi T; Miyazawa K; Kimura Y; Ohyashiki JH
Leukemia; 2007 Dec; 21(12):2544-5. PubMed ID: 17611562
[No Abstract] [Full Text] [Related]
13. A case of Budd-Chiari syndrome secondary to multiple thrombogenic conditions: a case report and review of literature.
Abut E; Güveli H; Kendir T; Bölükbaş C; Ince AT; Dalay AR; Kurdaş OO
Turk J Gastroenterol; 2004 Jun; 15(2):100-3. PubMed ID: 15334320
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of JAK29V617F) mutation in intra-abdominal venous thrombosis.
Deepak A; Punamiya S; Patel N; Parekh S; Mehta S; Shah N
Trop Gastroenterol; 2011; 32(4):279-84. PubMed ID: 22696908
[TBL] [Abstract][Full Text] [Related]
15. [Budd-Chiari syndrome with fatal outcome in a patient with polycythemia vera and antiphospholipid antibody syndrome].
Bragagni G; Brogna R; Dazzani F; Franceschetti P; Zoli G
Ann Ital Med Int; 2004; 19(3):184-8. PubMed ID: 15529946
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of the JAK2 V617F mutation for latent chronic myeloproliferative disorders in patients with Budd-Chiari syndrome and/or portal vein thrombosis.
Karaköse S; Oruç N; Zengin M; Akarca US; Ersöz G
Turk J Gastroenterol; 2015 Jan; 26(1):42-8. PubMed ID: 25698270
[TBL] [Abstract][Full Text] [Related]
17. Budd-Chiari syndrome secondary to polycythemia vera. A case report.
Buzas C; Sparchez Z; Cucuianu A; Manole S; Lupescu I; Acalovschi M
J Gastrointestin Liver Dis; 2009 Sep; 18(3):363-6. PubMed ID: 19795034
[TBL] [Abstract][Full Text] [Related]
18. Subacute Budd-Chiari syndrome associated with polycythemia vera and factor V Leiden mutation.
Simsek S; Verheesen RV; Haagsma EB; Lourens J
Neth J Med; 2000 Aug; 57(2):62-7. PubMed ID: 10924943
[TBL] [Abstract][Full Text] [Related]
19. Early medical treatment is life saving in acute Budd-Chiari due to polycythemia vera.
Karti SS; Yilmaz M; Kosucu P; Altun E; Kesen J; Arslan M; Ozgur O; Ovali E
Hepatogastroenterology; 2003; 50(50):512-4. PubMed ID: 12749260
[TBL] [Abstract][Full Text] [Related]
20. Budd-Chiari syndrome has different presentations and disease severity during adolescence.
Shukla A; Bhatt P; Gupta DK; Modi T; Patel J; Gupte A; Meshram M; Bhatia S
Hepatol Int; 2018 Nov; 12(6):560-566. PubMed ID: 29971683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
